We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Target practice

11 November 2019 By John Foley

A goal of generating $5 bln of new revenue at the $79 bln firm sounded great two years ago, but makes little sense when the top line reflects market gyrations. Targets have their place, but if they’re hard to verify and don’t obviously benefit shareholders, they need a rethink.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)